Brand Name(s):Palexia SR
Indication:Severe chronic pain
Drug Safety Update
Tapentadol (Palexia): risk of seizures and reports of serotonin syndrome when co-administered with other medicines
For palliative care and chronic pain patients only as 3rd line use as per Formulary guidance.